Pallas Health vs Start Willow: Clinician Choice vs Fast Shipping

Pallas Health vs Start Willow: quick verdict up front. Pallas Health combines clinician selection of brand-name pens or compounded semaglutide and tirzepatide with an all-in plan price starting at $139 for compounded semaglutide, while Start Willow focuses on direct-pay compounded semaglutide with a 3 day delivery guarantee starting at $249 per month. If you want clinician flexibility between branded and compounded options choose Pallas Health; if you prioritize faster guaranteed shipping and a straightforward direct-pay semaglutide plan choose Start Willow.

How the two providers differ at a glance

This comparison uses only documented provider claims. The most distinctive differences are: pricing structure and starting cost, brand-name versus compounded availability, shipping and delivery commitments, clinician review and visit requirements, and regulatory notes about compounded medications.

Pricing and payment model

Pallas Health documents compounded semaglutide at $139 for the first month, then $597 every 12 weeks, which the source frames as a $199 per month average. Pallas also lists compounded tirzepatide at $179 first month, then $897 every 12 weeks or a $299 per month average. Brand-name monthly cash prices are shown for Wegovy, Ozempic, Zepbound and Mounjaro at higher monthly cash pay figures. Pallas is cash-pay only and does not bill insurance.

View Start Willow semaglutide pricing and shipping

Start Willow lists semaglutide from $249 for the first month, rising to $299 per month ongoing. Start Willow emphasizes no insurance and no membership fees with a direct-pay model. The Start Willow source notes the $299 ongoing rate is among the higher rates on the list.

Medication options and clinician selection

Pallas Health presents both routes from a single intake: FDA-approved brand-name GLP-1s and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA when a brand medication is not the right fit. Pallas states a US-licensed clinician reviews health history and personalizes the plan. Start Willow offers compounded medications comparable to Ozempic and tirzepatide and says a licensed clinician approves prescriptions after online review. Start Willow does not offer branded finished products according to the supplied evidence.

Shipping and delivery commitments

Start Willow guarantees delivery in 3 days or less from its licensed pharmacy network and highlights same day prescription processing and free 2-Day shipping when in stock. Pallas advertises free expedited and discreet shipping on every plan, but the captured evidence does not state a comparable 3 day delivery guarantee.

Care model, visits, and availability

Pallas describes a 100 percent online program that is asynchronous in most states, noting 43 of 50 states need no video visit and that a video visit is required in seven states plus Washington, D.C. Pallas includes provider care, check-ins and messaging inside the plan price and no membership fee. Start Willow describes a fully online direct-pay model with physician collaboration on compounded formulations and no in-person visits or insurance forms. Both platforms describe clinician review before prescribing.

Regulatory and safety notes

Both sources explicitly state compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness or quality. Pallas adds that Pallas does not manufacture or compound medication and that compounded medications are prepared by US licensed compounding pharmacies and may differ in appearance from site images. Start Willow notes state licensed compounding pharmacies operate under state board oversight and are required to meet USP compounding standards.

Pallas emphasizes clinician choice between brand-name pens and compounded preparations and notes compounded plans are priced by medication rather than by milligram so titration does not raise plan price. Start Willow emphasizes bypassing insurance preauthorization and a fast delivery promise. The sources do not supply head to head outcome data or patient eligibility beyond clinician review.

Which to choose

Choose Pallas Health if you want a clinician to choose between branded GLP-1 pens and per-patient compounded semaglutide or tirzepatide, prefer an all-in plan price that includes provider care and messaging, and value compounded plans priced by medication rather than by milligram. Choose Start Willow if you need a direct-pay, no-insurance option that guarantees delivery in 3 days or less and you are seeking a compounded semaglutide plan with same day prescription processing and free 2-Day shipping when in stock.

Check Start Willow semaglutide delivery and care

In summary, Pallas Health vs Start Willow centers on clinician flexibility and brand access versus delivery speed and a simple direct-pay semaglutide offering. Use the documented pricing, shipping, and clinician rules above to decide which match your priorities.